Automated Analyzers Market Size, Share, Growth Trends, and Industry Analysis, By Type (Automated Liquid Handlers, Automated Plate Handlers, Robotic Arms, Automated Storage & Retrieval Systems (ASRS)), By Application (Drug Discovery, Genomics, Proteomics, Bio Analysis, Analytical Chemistry, Clinical Diagnostics), Regional Insights and Forecast to 2035

Automated Analyzers Market Overview

Global Automated Analyzers Market size is projected to reach USD 10821.59 Million by 2035, rising from USD 5821.13 Million in 2026 at a CAGR of 7.13%.

The global Automated Analyzers Market is expanding as laboratories adopt automated testing, sample handling, analytical chemistry, immunoassay, hematology, and biochemical workflows. In 2024, immuno-based analyzers represented approximately 42.38% of the automated analyzer type mix, demonstrating the importance of automated immunodiagnostic testing. North America accounted for approximately 35.0% of the global Automated Analyzers Market in 2026, supported by advanced laboratory infrastructure and strong adoption of automated platforms. Modern systems increasingly integrate robotics, software, artificial intelligence, barcode tracking, and laboratory information systems. Automated analyzers can process hundreds or thousands of tests daily, reducing manual intervention, improving repeatability, and supporting laboratories handling continuously increasing diagnostic and research workloads.

The United States represents the largest national market within North America, supported by approximately 35,000 clinical laboratories and extensive use of automated diagnostic instrumentation. Large clinical laboratories increasingly deploy integrated chemistry and immunoassay systems capable of processing hundreds of tests per hour. Danaher's DxC 500i, cleared in 2025, can perform up to 800 chemistry tests and 100 immunoassay tests per hour. Roche's cobas c 703 introduced in 2024 can deliver up to 2,000 chemistry tests per hour with 70 reagent positions, illustrating the high-throughput direction of the U.S. automated analyzers market. Hospitals, reference laboratories, pharmaceutical companies, biotechnology firms, and research institutions remain important purchasers.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Approximately 78% of laboratories identify higher testing workloads as an important automation consideration, while 72% prioritize improved workflow consistency and 68% emphasize reduction of repetitive manual activities across diagnostic and research workflows.
• Major Market Restraint: Approximately 64% of laboratories identify equipment acquisition costs as a significant barrier, while 57% cite integration complexity and 49% identify maintenance and validation requirements as important constraints affecting automated analyzer adoption.
• Emerging Trends: Approximately 61% of laboratories are prioritizing digital connectivity, 54% are evaluating AI-supported analytics, and 48% are increasing interest in modular automation platforms capable of supporting multiple analytical workflows within a single laboratory environment.
• Regional Leadership: North America represents approximately 35.0% of global automated analyzer demand, Europe accounts for approximately 27%, Asia-Pacific approximately 29%, and Middle East & Africa approximately 9%, reflecting different levels of laboratory automation maturity.
• Competitive Landscape: The leading automated analyzer competitors collectively represented approximately 31.69% of the market in 2023, with Roche at 4.26%, Danaher at 4.12%, Thermo Fisher at 4.02%, and Abbott at 3.70%.
• Market Segmentation: Immuno-based analyzers represented 42.38% of type demand in 2024, while drug discovery represented approximately 39.0% of laboratory automation application demand in 2025, demonstrating strong research and diagnostic utilization.
• Recent Development: In 2025, Tecan launched Veya with AI-enhanced automation and multi-omics workflow capabilities, while Danaher's DxC 500i received U.S. FDA 510(k) clearance and supports up to 800 chemistry and 100 immunoassay tests per hour.

Latest Trends

The Automated Analyzers Market is increasingly characterized by high-throughput processing, modular architecture, AI-supported workflow management, and integrated analytical platforms. In 2025, automated liquid handlers represented approximately 34.9% of total laboratory automation equipment, highlighting the importance of automated sample preparation. Immuno-based analyzers accounted for 42.38% of automated analyzer demand in 2024, reflecting continued adoption in clinical diagnostics. Modern clinical analyzers are also moving toward integrated chemistry and immunoassay configurations. Danaher's DxC 500i, cleared in 2025, supports up to 800 chemistry tests and 100 immunoassay tests per hour, while Roche's cobas c 703 introduced in 2024 supports up to 2,000 chemistry tests per hour. AI is increasingly incorporated into image interpretation, quality monitoring, predictive maintenance, scheduling, and workflow optimization. Tecan's Veya, launched in 2025, combines AI-enhanced automation with multi-omics workflows. Laboratories are also emphasizing connectivity with LIMS, LIS, barcode systems, and cloud-enabled analytics. These trends are increasing demand for analyzers that can operate continuously, reduce hands-on time, standardize sample processing, and generate traceable digital records across increasingly complex laboratory environments.

Market Dynamics

Automated Analyzers Market dynamics are shaped by laboratory consolidation, increasing diagnostic workloads, precision requirements, pharmaceutical research, genomics, proteomics, and the need to reduce repetitive manual work. Automated liquid handling accounted for 34.9% of total laboratory automation equipment in 2025, while drug discovery represented approximately 39.0% of application demand. At the diagnostic end, hospitals represented approximately 46.74% of clinical chemistry analyzer end-user demand in 2025.

DRIVER

Rising demand for high-throughput laboratory testing and standardized workflows.

Automated analyzers are increasingly deployed because laboratories must process larger numbers of samples while maintaining consistent analytical performance. Automated liquid handlers represented approximately 34.9% of laboratory automation equipment in 2025, showing the importance of automated sample preparation. Clinical laboratories are also moving toward integrated chemistry and immunoassay systems capable of continuous processing. Roche's cobas c 703 can process up to 2,000 chemistry tests per hour, while Danaher's DxC 500i supports up to 800 chemistry tests and 100 immunoassay tests per hour. Pharmaceutical and biotechnology laboratories are another important demand source because high-throughput screening can involve thousands of samples in a single experimental campaign. Automation reduces repetitive pipetting, sample movement, reagent dispensing, and analytical preparation tasks. Increased adoption of genomics, proteomics, cell analysis, and molecular diagnostics further strengthens demand for automated analyzers. As laboratories consolidate testing into larger facilities, the economic and operational value of instruments capable of processing high sample volumes becomes increasingly important.

RESTRAINT

High acquisition, integration, validation, and maintenance requirements.

Automated analyzer systems can require substantial capital expenditure, specialized installation, software integration, calibration, validation, and operator training. Approximately 64% of laboratories identify acquisition cost as an important automation barrier in industry surveys and market assessments, while approximately 57% highlight integration complexity. A fully automated workflow can involve analyzers, robotic arms, liquid handlers, conveyors, barcode readers, storage systems, LIMS, LIS, and data-management software, creating multiple integration points. Regulatory laboratories may also need extensive validation before introducing automated workflows into routine testing. Equipment downtime can affect hundreds or thousands of samples when a centralized system operates continuously. Smaller laboratories may therefore prefer modular analyzers rather than large total-laboratory automation systems. Compatibility between instruments from different manufacturers can also create additional technical costs. These factors can slow adoption even when the long-term operational benefits of automation are significant.

OPPORTUNITY

Expansion of AI-enabled, modular, connected, and multi-omics laboratory automation.

The strongest opportunity lies in combining automated analyzers with AI, robotics, digital analytics, and modular workflow architecture. Tecan introduced Veya in 2025 as a scalable liquid-handling platform incorporating AI-enhanced automation and multi-omics capabilities. The integration of genomics, proteomics, transcriptomics, and cell-analysis workflows creates demand for systems capable of handling multiple sample types and protocols. Genomics and proteomics laboratories increasingly require precise liquid handling, contamination control, sample identification, and automated data transfer. Pharmaceutical companies can also use automated analyzers for screening, assay development, biomarker analysis, and preclinical research. Emerging laboratories in Asia-Pacific represent another important opportunity because investment in biotechnology and diagnostic infrastructure is increasing. Modular automation allows laboratories to begin with a single workstation and add robotic arms, storage, plate handling, or analytical modules as workload increases, making automation more accessible to mid-sized facilities.

CHALLENGE

Maintaining interoperability, analytical accuracy, cybersecurity, and regulatory compliance across complex automated workflows.

Modern automated laboratories can connect 5 or more major system categories, including analyzers, robotic equipment, software, storage, and laboratory information systems. Every connection introduces potential compatibility, communication, or data-management issues. Analytical laboratories also require high reproducibility because small deviations in sample volume, reagent concentration, incubation time, or temperature can affect results. Automated systems must therefore maintain accurate calibration and quality control across thousands of operations. Cybersecurity is becoming increasingly important as analyzers connect to laboratory networks and digital systems. Regulatory requirements add another layer of complexity, particularly for clinical diagnostic applications. Laboratories must demonstrate that automated workflows produce reliable results and preserve data integrity. Manufacturers therefore face pressure to develop open interfaces, standardized communication protocols, secure software, remote monitoring, and automated quality-control tools while maintaining instrument performance across different laboratory environments.

Segmentation Analysis

The Automated Analyzers Market can be segmented by equipment type and application. Equipment segmentation includes Automated Liquid Handlers, Automated Plate Handlers, Robotic Arms, and Automated Storage & Retrieval Systems (ASRS). Automated liquid handlers represent the largest equipment category, with approximately 34.9% share within total laboratory automation equipment in 2025. Application segmentation includes drug discovery, genomics, proteomics, bioanalysis, analytical chemistry, and clinical diagnostics. Drug discovery represented approximately 39.0% of laboratory automation application demand in 2025, while clinical diagnostics remains a major high-volume application because automated analyzers support continuous testing and standardized analytical workflows.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

By Type

Automated Liquid Handlers: Automated Liquid Handlers represented approximately 34.9% of total laboratory automation equipment demand in 2025, making them the largest equipment category in the specified segmentation. These systems automate pipetting, dispensing, dilution, reagent addition, sample transfer, and plate preparation. Their importance is particularly high in genomics, drug discovery, proteomics, and clinical diagnostics. Advanced systems can coordinate multiple channels and laboratory instruments within one workflow, reducing manual pipetting and improving repeatability. High-throughput genomic workflows can require thousands of liquid transfers, making automation particularly valuable.

Automated Plate Handlers: Automated Plate Handlers represented approximately 18% of the broader laboratory automation equipment mix in 2025 and are critical for laboratories processing microplates. These systems transport, orient, sort, and position plates between instruments, storage units, and analytical stations. Their importance is especially strong in high-throughput screening, drug discovery, genomics, proteomics, and biochemical assays. A single automated workflow can move hundreds of plates through multiple analytical stages, creating a strong requirement for precise plate tracking. Automated plate handlers also reduce manual transportation and minimize the risk of sample mix-ups.

Robotic Arms: Robotic Arms accounted for approximately 15% of the specified laboratory automation equipment mix in 2025 and serve as flexible movement platforms connecting multiple laboratory instruments. A robotic arm can transfer samples, microplates, tubes, and consumables between liquid handlers, analyzers, incubators, centrifuges, and storage systems. Their value increases when laboratories need flexible automation across more than 3 instrument categories. Robotic arms also support customized workflows where fixed automation tracks would be unsuitable. Collaborative robotics is emerging as a practical option for laboratories seeking automation without constructing large fully automated environments.

Automated Storage & Retrieval Systems (ASRS): Automated Storage & Retrieval Systems represented approximately 10% of the specified laboratory automation equipment mix in 2025 and are increasingly important for laboratories managing large sample inventories. ASRS platforms can automatically store and retrieve tubes, plates, reagents, and biological samples according to digitally recorded locations. This capability is valuable in biobanks, clinical laboratories, pharmaceutical screening centers, and genomics facilities. Large laboratories may manage hundreds of thousands of individual samples, making manual storage increasingly inefficient. Barcode identification and automated retrieval reduce location errors and improve traceability.

By Application

Drug Discovery: Drug Discovery represented approximately 39.0% of laboratory automation application demand in 2025, making it the leading application in the specified segmentation. Pharmaceutical discovery workflows can require thousands of compounds to be tested across multiple assays, creating strong demand for liquid handlers, plate handlers, robotic arms, and automated analyzers. High-throughput screening depends on precise dispensing, repeatable incubation, plate movement, and automated analytical measurement. Automation also supports compound management, assay preparation, hit identification, and validation. AI-assisted laboratory systems are increasingly being integrated with automated workflows to prioritize experiments and identify anomalous results.

Genomics: Genomics represented approximately 13% of the application mix in 2025, supported by increasing use of automated sample preparation and sequencing workflows. Genomic laboratories frequently perform extraction, normalization, amplification, library preparation, pooling, and other repetitive processes requiring precise liquid handling. Beckman Coulter's Biomek Echo One, launched in 2024, combines the Echo 525 acoustic liquid handler with the Biomek i7 workstation and can automate several NGS preparation activities. Automation is particularly valuable because genomic workflows may involve hundreds of samples in a single batch. Barcode tracking reduces sample identification errors, while automated pipetting improves consistency.

Proteomics: Proteomics represented approximately 9% of the specified application market in 2025 and is increasingly dependent on automation because protein workflows involve multiple preparation and purification steps. Automated systems support sample preparation, digestion, purification, liquid transfer, plate handling, and integration with analytical instruments. Tecan introduced the Resolvex i300 module in 2024 to enhance proteomics workflows through integration with its Fluent platform. Automated preparation improves reproducibility when laboratories process hundreds of biological samples. Proteomics laboratories also increasingly combine protein measurements with genomics and metabolomics, creating demand for multi-omics automation.

Bio Analysis: Bio Analysis represented approximately 6% of application demand in 2025, covering laboratory workflows used to measure biological compounds, biomarkers, metabolites, and drug-related analytes. Automation reduces repetitive preparation steps and helps standardize sample handling before analytical measurement. Pharmaceutical laboratories use automated bioanalysis workflows during pharmacokinetic, pharmacodynamic, and biomarker studies. Robotic liquid handlers can prepare dilution series, standards, controls, and biological samples with high repeatability. Automated plate handling also supports large sample batches. The integration of laboratory information systems improves traceability by associating analytical results with sample identifiers and workflow records.

Analytical Chemistry: Analytical Chemistry represented approximately 7% of the specified application mix in 2025 and includes automated workflows for chemical identification, separation, quantification, and quality testing. Automation is increasingly used for sample preparation before chromatography, spectroscopy, mass spectrometry, and other analytical techniques. Automated analyzers reduce manual variability in dilution, extraction, filtration, and reagent addition. Pharmaceutical quality laboratories, chemical manufacturers, environmental laboratories, and academic research facilities use automation to increase testing consistency. Digital connectivity enables analytical results to be transferred automatically into laboratory information systems.

Clinical Diagnostics: Clinical Diagnostics represented approximately 26% of the specified application mix in 2025 and remains one of the most important high-volume applications for automated analyzers. Hospitals and reference laboratories use automated systems for chemistry, immunoassay, hematology, molecular testing, and other diagnostic workflows. Hospitals accounted for approximately 46.74% of clinical chemistry analyzer end-user demand in 2025. Modern systems can process hundreds or thousands of tests per hour, supporting continuous laboratory operations. Roche's cobas c 703 can reach approximately 2,000 chemistry tests per hour, while Danaher's DxC 500i supports up to 800 chemistry tests and 100 immunoassay tests per hour.

Regional Outlook

Regional performance varies according to healthcare infrastructure, laboratory consolidation, pharmaceutical research, regulatory standards, and automation investment. North America held approximately 35.0% of the Automated Analyzers Market in 2026, making it the leading region. Asia-Pacific represented approximately 29%, supported by expanding biotechnology and diagnostic infrastructure. Europe represented approximately 27%, while Middle East & Africa represented approximately 9%.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America

North America accounted for approximately 35.0% of the global Automated Analyzers Market in 2026, representing the largest regional share. The United States is the primary contributor because of its extensive hospital network, reference laboratory infrastructure, biotechnology ecosystem, pharmaceutical research activity, and established laboratory automation base. Major manufacturers including Danaher, Thermo Fisher Scientific, Agilent Technologies, and other diagnostic and analytical technology companies maintain significant commercial activity in the region. High-volume laboratories increasingly use integrated chemistry and immunoassay analyzers capable of processing hundreds or thousands of tests per hour. Danaher's DxC 500i received FDA 510(k) clearance in 2025 and supports up to 800 chemistry tests and 100 immunoassay tests per hour. The region also has strong demand for automated liquid handling, genomics, proteomics, and drug discovery systems. Pharmaceutical and biotechnology companies use robotic workflows for high-throughput screening and sample preparation. North American laboratories are also among the early adopters of AI-enabled laboratory software, predictive maintenance, digital quality control, and cloud-connected analytics.

Europe

Europe accounted for approximately 27% of the global Automated Analyzers Market in 2026, making it the second-largest regional market by estimated share. Germany, the United Kingdom, France, Italy, Switzerland, and the Netherlands are important markets because of established healthcare systems, pharmaceutical research, biotechnology development, and strong laboratory technology capabilities. European laboratories increasingly emphasize automation that improves traceability, reduces manual intervention, and supports regulatory compliance. Switzerland is particularly important as a laboratory automation technology center, with Tecan developing platforms for liquid handling, proteomics, genomics, and multi-omics. Tecan launched Veya in 2025, incorporating AI-enhanced automation and analytics capabilities. European laboratories are also adopting automated sample preparation for genomics, proteomics, and clinical diagnostics. Regulatory requirements create demand for validated workflows and high-quality digital records. The European market is characterized by strong interest in modular automation because laboratories differ significantly in size and testing volume. Large centralized diagnostic laboratories are installing integrated systems, while research facilities increasingly deploy flexible robotic workstations.

Asia-Pacific

Asia-Pacific represented approximately 29% of the Automated Analyzers Market in 2026, making it a major regional market and one of the most strategically important expansion areas. China, Japan, South Korea, India, Australia, and Singapore are key contributors. Increasing healthcare infrastructure, biotechnology investment, pharmaceutical manufacturing, genomics research, and diagnostic laboratory capacity are supporting demand for automation. China and India are particularly important because large patient populations generate substantial testing requirements. Japan has a mature laboratory automation ecosystem and strong demand for precision analytical equipment. South Korea is expanding biotechnology and advanced diagnostic research, while Singapore serves as an important regional life-science hub. Tecan established a direct sales presence in South Korea in 2024, illustrating the increasing importance of Asian laboratory markets. Asia-Pacific laboratories are increasingly adopting automated liquid handlers, robotic sample preparation, and integrated analyzers to address rising workloads and improve consistency. Automated genomics workflows are another major opportunity because sequencing and molecular testing are becoming more accessible.

Middle East & Africa

Middle East & Africa represented approximately 9% of the global Automated Analyzers Market in 2026, making it a smaller but increasingly important regional market. The Gulf Cooperation Council countries, South Africa, Israel, and selected North African markets are leading areas of adoption. Healthcare modernization programs in Saudi Arabia and the United Arab Emirates are supporting investments in advanced diagnostic laboratories, centralized testing facilities, and digital healthcare infrastructure. Automated analyzers are increasingly used for clinical chemistry, immunoassay, hematology, molecular testing, and research applications. Laboratories in larger metropolitan healthcare centers are adopting automated systems to improve throughput and reduce dependence on manual processing. South Africa remains an important laboratory technology market because of its established diagnostic infrastructure and research institutions. The region also has opportunities for compact and modular analyzers because smaller laboratories may not require large total-laboratory automation installations. Automated sample identification and barcode-based workflows can improve traceability in high-volume diagnostic settings. Demand is also supported by infectious-disease testing, chronic disease screening, pharmaceutical research, and expanding private healthcare networks.

List of Top Automated Analyzers Companies

• Thermo Scientific
• Danaher
• Hudson Robotics
• Becton Dickinson
• Synchron Lab
• Agilent Technologies
• Siemens Healthcare
• Tecan Group
• PerkinElmer
• Honeywell
• Bio-Rad
• Roche Holding AG
• Eppendorf AG
• Shimadzu
• Aurora Biomed

List of Top 2 Companies Market Share

• F. Hoffmann-La Roche Ltd. — 4.26%: Roche held the largest individual share of the global Automated Analyzers Market in 2023, according to published competitive-market estimates.
• Danaher Corporation — 4.12%: Danaher ranked second with approximately 4.12% share in 2023, supported by Beckman Coulter's clinical diagnostics and laboratory automation portfolio.

Investment Analysis and Opportunities

Investment opportunities in the Automated Analyzers Market are increasingly concentrated in high-throughput diagnostics, laboratory robotics, AI-enabled software, automated liquid handling, genomics, and integrated laboratory platforms. Automated liquid handlers represented approximately 34.9% of laboratory automation equipment in 2025, making this an important investment category. Drug discovery represented approximately 39.0% of laboratory automation applications, creating opportunities for investors targeting pharmaceutical screening and assay automation. Genomics is another attractive segment because automated NGS preparation can involve hundreds of samples per batch. AI-enabled laboratory systems are attracting strategic investment because predictive maintenance, workflow optimization, and automated quality control can improve instrument utilization. Asia-Pacific is particularly attractive because it represented approximately 29% of the global Automated Analyzers Market in 2026 and continues to expand biotechnology and diagnostic infrastructure. Investors can also target modular systems designed for mid-sized laboratories because these platforms reduce the barrier associated with large-scale total automation. Service contracts, software upgrades, consumables, calibration, validation, and workflow integration create additional investment opportunities beyond instrument sales.

New Product Development

New product development in the Automated Analyzers Market is focused on higher throughput, smaller footprints, AI integration, multi-omics compatibility, improved connectivity, and automated quality control. In 2025, Tecan launched Veya as a digital liquid-handling platform incorporating AI-enhanced automation and analytics. In 2024, Beckman Coulter introduced the Biomek Echo One System, combining the Echo 525 acoustic liquid handler with the Biomek i7 Hybrid Workstation for genomic sample preparation. Roche introduced the cobas c 703 and cobas ISE neo in 2024, with the c 703 capable of up to 2,000 chemistry tests per hour. Danaher's DxC 500i received FDA 510(k) clearance in 2025 and supports up to 800 chemistry tests and 100 immunoassay tests per hour. Product developers are increasingly integrating barcode tracking, robotic movement, automated reagent management, predictive maintenance, and digital analytics into analyzer platforms. Multi-omics is another major development area because genomics, proteomics, transcriptomics, and cell biology increasingly share laboratory infrastructure. New analyzers are therefore being designed for interoperability rather than isolated operation. Modular architectures allow laboratories to add additional instruments, robotic arms, storage modules, or software without replacing the complete system.

Five Recent Developments (2023-2025)

• 2025 — Tecan launched Veya: Tecan introduced Veya at the SLAS conference in January 2025, incorporating AI-enhanced automation, prebuilt workflows, analytics, and multi-omics capabilities for laboratories of different sizes.
• 2025 — Danaher introduced DxC 500i: The system received U.S. FDA 510(k) clearance in March 2025 and supports up to 800 chemistry tests and 100 immunoassay tests per hour.
• 2024 — Beckman Coulter launched Biomek Echo One: The system combined the Echo 525 acoustic liquid handler and Biomek i7 workstation to automate multiple genomic sample-preparation steps, including extraction, fragmentation, ligation, normalization, and pooling.
• 2024 — Roche expanded cobas pro: Roche introduced the cobas c 703 and cobas ISE neo in June 2024; the c 703 supports up to 2,000 chemistry tests per hour and includes 70 reagent positions.
• 2023 — Tecan introduced Resolvex Prep: Tecan launched Resolvex Prep in October 2023 for automated sample preparation supporting chromatography workflows, strengthening automation across analytical laboratory processes.

Report Coverage

The Automated Analyzers Market report covers product types, laboratory automation technologies, applications, regional markets, competitive positioning, technology developments, investment opportunities, and emerging trends. The equipment scope includes 4 principal categories: Automated Liquid Handlers, Automated Plate Handlers, Robotic Arms, and Automated Storage & Retrieval Systems. Application coverage includes 6 major areas: Drug Discovery, Genomics, Proteomics, Bio Analysis, Analytical Chemistry, and Clinical Diagnostics. Regional coverage includes 4 major regions: North America, Europe, Asia-Pacific, and Middle East & Africa. The report evaluates market dynamics using measurable indicators such as equipment share, application share, regional share, testing throughput, product launches, and competitive positioning. It also examines AI integration, digital laboratory connectivity, robotics, automated sample management, multi-omics workflows, and high-throughput diagnostics. Competitive coverage includes 15 companies specified for analysis, including Thermo Fisher Scientific, Danaher, Hudson Robotics, Becton Dickinson, Tecan Group, Agilent Technologies, Siemens Healthcare, Roche, Bio-Rad, Eppendorf, Shimadzu, and Aurora Biomed.

Automated Analyzers Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 5821.13 Million in 2026
Market Size Value By	USD 10821.59 Million by 2035
Growth Rate	CAGR of 7.13% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Automated Liquid Handlers Automated Plate Handlers Robotic Arms Automated Storage & Retrieval Systems (ASRS) By Application : Drug Discovery Genomics Proteomics Bio Analysis Analytical Chemistry Clinical Diagnostics
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample